Amyloid PET Disclosure in ADNI‐4: The Clinician Experience
Clinicians disclosing amyloid PET results in ADNI-4 report high confidence, adequate participant and study partner understanding, and few challenges. These data from clinicians, in combination with participant data, will inform future disclosure practices in both research and care.
Authors
- Emily A. Largent (ORCID: https://orcid.org/0000-0002-7536-5077)
- Josh D. Grill
- R. Petersen
- Kristin Harkins (ORCID: https://orcid.org/0000-0001-5360-1043)
- Ozioma C. Okonkwo
- Paul S. Aisen
- Claire M Erickson
- Monica G Rivera Mindt
- Susan M. Landau
- Kyra O’Brien
- Jason Karlawish
- Michael S. W. Weiner
Institutions
- University of Southern California (US)
- University of Wisconsin–Madison (US)
- Fordham University (US)
- University of California, San Francisco (US)
- University of California, Irvine (US)
- Mayo Clinic in Arizona (US)
- Wisconsin Division of Public Health (US)
- Banner Alzheimer’s Institute
- University of Pennsylvania (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_106634
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00